Doctor Bethlehem Mengesha
University of Ottawa Heart Institute, Ottawa (Canada)
Reversible P2Y12 inhibitor versus irreversible P2Y12 inhibitor in ACS patients undergoing PCI (the acute coronary syndrome israeli survey (ACSIS)
Event: ESC Congress 2021 - The Digital Experience
Topic: Pharmacotherapy
Session: Congress committee e-posters choice in CAD/ACS/ACC
ESC 365 is supported by
